Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

110.05
-0.5200-0.47%
Post-market: 108.00-2.0500-1.86%19:34 EDT
Volume:474.17K
Turnover:52.51M
Market Cap:9.05B
PE:-31.04
High:113.00
Open:110.57
Low:109.93
Close:110.57
52wk High:130.05
52wk Low:36.65
Shares:82.26M
Float Shares:63.53M
Volume Ratio:0.89
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5458
EPS(LYR):-3.6900
ROE:-27.09%
ROA:-17.16%
PB:5.88
PE(LYR):-29.82

Loading ...

Kymera Therapeutics Files Initial Beneficial Ownership Statement for Chief Medical Officer Terence Rooney

Reuters
·
7 hours ago

Kymera Therapeutics Appoints Terence Rooney, Md, as Chief Medical Officer

THOMSON REUTERS
·
10 hours ago

Press Release: Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer

Dow Jones
·
10 hours ago

Mizuho Raises Price Target on Kymera Therapeutics to $140 From $120, Keeps Outperform Rating

MT Newswires Live
·
Jul 16

Kymera Therapeutics Inc : Mizuho Raises Target Price to $140 from $120

THOMSON REUTERS
·
Jul 16

Kymera Therapeutics Shares Fall After RBC Downgrade

MT Newswires Live
·
Jul 14

Kymera Therapeutics Cut to Sector Perform from Outperform by RBC Capital

Dow Jones
·
Jul 13

U.S. Stocks on the Move-american Express, Deckers, Q32 Bio

Reuters
·
Jul 13

RBC Downgrades Kymera Therapeutics to Sector Perform From Outperform, Lifts Price Target to $115 From $106, Keeps Speculative Risk

MT Newswires Live
·
Jul 13

Kymera Therapeutics Inc : RBC Cuts to Sector Perform from Outperform; Raises Target Price to $115 from $106

THOMSON REUTERS
·
Jul 13

Does Leadership Hire And Benchmark Additions Change The Bull Case For Kymera Therapeutics (KYMR)?

Simply Wall St.
·
Jul 11

Kymera CEO Nello Mainolfi Disposes of USD 5.95 Million in Common Shares

Reuters
·
Jul 08

Kymera Therapeutics Appoints Elizabeth Laws as SVP, Kt-621 Development Program Leader

Reuters
·
Jul 07

Kymera Therapeutics Appoints Elizabeth Laws, Ph.d., as Senior Vice President, Global Program Team Leader for Kt-621, First-in-class, Oral Stat6 Degrader

THOMSON REUTERS
·
Jul 07

German Pension Reform Turns Savers into Investors. That Will Fuel the Market. 13D Filings

Dow Jones
·
Jul 03

Kymera Therapeutics (KYMR) Stock Looks Fully Priced After A 405% Run

Simply Wall St.
·
Jul 03

Kymera CFO Bruce Jacobs Sells USD 8.67 Million in Common Shares

Reuters
·
Jul 03

Kymera Therapeutics (KYMR) Is Up 16.7% After KT-621 Trial Acceleration And Index Additions Has The Bull Case Changed?

Simply Wall St.
·
Jul 01

Kymera Therapeutics Director Bruce Booth Reports $57.91 Million Common Share Disposal

Reuters
·
Jul 01

Kymera Therapeutics is Maintained at Buy by B of a Securities

Dow Jones
·
Jun 30